#Israel #Rehovot #Drug Discovery #Evogene #ChemPass AI

Evogene to Showcase Innovative Solutions at AI Drug Discovery Roadshow

Evogene Ltd., a leader in computational chemistry, is gearing up for an exciting event on the U.S. East Coast. From November 2 to 5, 2026, the company will take part in an AI Drug Discovery Roadshow organized by the Israel Export Institute and TradeIL. The event focuses on connecting Israel's pioneering AI-driven drug discovery firms with U.S. investors, pharmaceutical companies, and potential strategic partners.

A Gateway to New Connections

The roadshow represents a crucial opportunity for Evogene to solidify its presence in the U.S. pharmaceutical landscape and expand its strategic relationships. The company’s President and CEO, Mr. Ofer Haviv, will lead the presentations at various locations including New York, New Jersey, Philadelphia, Washington, D.C., and Maryland. He will showcase Evogene's advanced computational chemistry platform, ChemPass AI™, designed for the generative discovery and optimization of small molecules.

About ChemPass AI™

ChemPass AI™ is a cutting-edge generative AI platform that explores vast chemical spaces to identify and optimize novel small molecules tailored to meet essential parameters for drug development. This innovative technology can significantly expedite the discovery process and enhance the profile quality of molecules intended for pharmaceutical applications.

By participating in the AI Drug Discovery Roadshow, Evogene aims not only to engage with key industry stakeholders but also to promote its role as a critical enabler of collaborative drug discovery alongside pharmaceutical and biotech companies. During the event, Mr. Haviv is open to meetings with interested parties to discuss potential collaborations and investment opportunities.

Roadshow Details

• - Dates: November 2-5, 2026
• - Locations: New York, New Jersey, Philadelphia, Washington, D.C., and Maryland
• - Organizers: Israel Export Institute and TradeIL

Evogene's drive to innovate in drug discovery underscores its commitment to leveraging AI technology in addressing urgent needs in both the pharmaceutical and agricultural sectors. They strive for breakthroughs that align scientific progress with market requirements, ensuring that solutions are grounded in real-world applications.

Looking Ahead

This roadshow is a significant step for Evogene as it continues to work on ambitious projects aimed at transforming the drug discovery landscape. The company positions itself at the forefront of the biotechnology sector, ready to explore partnerships that can advance therapeutic innovation. The firm is excited about the possibilities that lie ahead and is eager to engage in meaningful discussions during the roadshow.

Investors and partners interested in scheduling a meeting with Evogene can reach out directly to discuss collaborative opportunities.

For comprehensive insight into Evogene's capabilities and upcoming endeavors, visit Evogene’s official website.